1. Home
  2. BZUN vs CRBP Comparison

BZUN vs CRBP Comparison

Compare BZUN & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Baozun Inc.

BZUN

Baozun Inc.

HOLD

Current Price

$2.95

Market Cap

164.5M

ML Signal

HOLD

CRBP

Corbus Pharmaceuticals Holdings Inc.

HOLD

Current Price

$7.22

Market Cap

190.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BZUN
CRBP
Founded
2007
2009
Country
China
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
164.5M
190.3M
IPO Year
2014
2014

Fundamental Metrics

Financial Performance
Metric
BZUN
CRBP
Price
$2.95
$7.22
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
★ $45.50
AVG Volume (30 Days)
189.8K
★ 941.1K
Earning Date
05-20-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $4,822,272.00
Revenue This Year
$7.89
N/A
Revenue Next Year
$6.16
$116.00
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 97.62
52 Week Low
$2.07
$6.33
52 Week High
$4.27
$20.56

Technical Indicators

Market Signals
Indicator
BZUN
CRBP
Relative Strength Index (RSI) 57.54 30.93
Support Level $2.66 $6.33
Resistance Level $2.98 $8.54
Average True Range (ATR) 0.10 0.74
MACD 0.02 -0.15
Stochastic Oscillator 49.00 16.86

Price Performance

Historical Comparison
BZUN
CRBP

About BZUN Baozun Inc.

Baozun Inc is engaged to provide its customers with end-to-end e-commerce solutions including the sales of apparel, home and electronic products, online store design and setup, visual merchandising and marketing, online store operations, customer services, warehousing and order fulfillment, as well as the holistic brand management, including tactic positioning, branding and marketing, retail and e-commerce operations, supply chain and logistics, and technology empowerment. It has two operating segments: E-Commerce (encompassing BEC and BZI) and Brand Management (representing BBM). The company generates maximum of its revenue from E-Commerce (encompassing BEC and BZI) segment.

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a clinical stage company focused on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing inventive scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Share on Social Networks: